Israel Englander Dexcom Inc Put Options Transaction History

Millennium Management LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$110.31 - $140.45 $15.6 Million - $19.8 Million	-141,100 Reduced 79.54%	36,300 $4.12 Million
Q1 2024 May 15, 2024	BUY	$114.22 - $140.1 $1.8 Million - $2.21 Million	15,800 Added 9.78%	177,400 $24.6 Million
Q4 2023 Feb 14, 2024	SELL	$75.49 - $124.16 $19.1 Million - $31.4 Million	-253,300 Reduced 61.05%	161,600 $20.1 Million
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $17.3 Million - $20.1 Million	153,700 Added 58.84%	414,900 $53.3 Million
Q1 2023 May 15, 2023	SELL	$104.0 - $122.92 $32.6 Million - $38.6 Million	-313,900 Reduced 54.58%	261,200 $30.3 Million
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $8.14 Million - $11.8 Million	95,800 Added 19.99%	575,100 $65.1 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $3.2 Million - $3.95 Million	41,900 Added 9.58%	479,300 $38.6 Million

1,057

358M

4.11M

3.63M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $26.5B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.